Global Endocrinology Drugs Market By Therapy Area (Diabetes, Human Growth Hormone (hGH), Thyroid Hormone Disorders, Adrenal Insufficiency, and Other Therapy Areas), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Sep 2024
Report ID: 129390
Number of Pages:
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Endocrinology Drugs Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Endocrinology Drugs Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Endocrinology Drugs Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Area, 2019-2033
  - 3.3. Global Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
    3.3.1. Diabetes Drugs
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Human Growth Hormone (hGH)
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
    3.3.3. Thyroid Hormone Disorders
    3.3.3.1. Insights
    3.3.3.2. Key Takeaways
    3.3.4. Adrenal Insufficiency
    3.3.4.1. Insights
    3.3.4.2. Key Takeaways
    3.3.5. Other Therapy Areas
    3.3.5.1. Insights
    3.3.5.2. Key Takeaways
  - 3.4. Global Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 3.5. Global Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
    3.5.1. Hospital Pharmacies
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Retail Pharmacies
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Online Pharmacies
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
- 4. Global Endocrinology Drugs Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Endocrinology Drugs Market Attractiveness Analysis, By Region
- 5. North America Endocrinology Drugs Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Area, 2019-2033
  - 5.3. North America Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
  - 5.4. North America Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 5.5. North America Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 5.6. North America Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.7. North America Endocrinology Drugs Market Attractiveness Analysis, By Country
    5.7.1. The US
    5.7.2. Canada
- 6. Europe Endocrinology Drugs Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Area, 2019-2033
  - 6.3. Europe Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
  - 6.4. Europe Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 6.5. Europe Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 6.6. Europe Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.7. Europe Endocrinology Drugs Market Attractiveness Analysis, By Country
    6.7.1. Germany
    6.7.2. The UK
    6.7.3. France
    6.7.4. Spain
    6.7.5. Italy
    6.7.6. Russia
    6.7.7. Netherland
    6.7.8. Rest of Europe
- 7. Asia Pacific Endocrinology Drugs Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Area, 2019-2033
  - 7.3. Asia Pacific Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
  - 7.4. Asia Pacific Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 7.5. Asia Pacific Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 7.6. Asia Pacific Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.7. Asia Pacific Endocrinology Drugs Market Attractiveness Analysis, By Country
    7.7.1. China
    7.7.2. Japan
    7.7.3. South Korea
    7.7.4. India
    7.7.5. Australia
    7.7.6. New Zealand
    7.7.7. Singapore
    7.7.8. Thailand
    7.7.9. Vietnam
    7.7.10. Rest of Asia Pacific
- 8. Latin America Endocrinology Drugs Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Area, 2019-2033
  - 8.3. Latin America Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
  - 8.4. Latin America Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 8.5. Latin America Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 8.6. Latin America Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.7. Latin America Endocrinology Drugs Market Attractiveness Analysis, By Country
    8.7.1. Brazil
    8.7.2. Mexico
    8.7.3. Rest of Latin America
- 9. Middle East & Africa Endocrinology Drugs Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Area, 2019-2033
  - 9.3. Middle East & Africa Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
  - 9.4. Middle East & Africa Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  - 9.5. Middle East & Africa Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
  - 9.6. Middle East & Africa Endocrinology Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.7. Middle East & Africa Endocrinology Drugs Market Attractiveness Analysis, By Country
    9.7.1. South Africa
    9.7.2. Saudi Arabia
    9.7.3. UAE
    9.7.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
  - 10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. Abbott Laboratories
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Acerus Pharmaceuticals Corp.
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Ascendis Pharma AS
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Bayer AG
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. Beta Cell NV
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. Biocon Ltd.
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Eli Lilly and Co.
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. Merck and Co. Inc.
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Novartis AG
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Novo Nordisk ASEndo International Plc
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
    10.7.11. F. Hoffmann La Roche Ltd.
    10.7.11.1. Company Details
    10.7.11.2. Business Overview
    10.7.11.3. Product Portfolio
    10.7.11.4. Financial Insights
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.11.6. SWOT Analysis
    10.7.11.7. Geographic Footprint
    10.7.12. GlaxoSmithKline Plc
    10.7.12.1. Company Details
    10.7.12.2. Business Overview
    10.7.12.3. Product Portfolio
    10.7.12.4. Financial Insights
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.12.6. SWOT Analysis
    10.7.12.7. Geographic Footprint
    10.7.13. Hanmi Pharm Co. Ltd.
    10.7.13.1. Company Details
    10.7.13.2. Business Overview
    10.7.13.3. Product Portfolio
    10.7.13.4. Financial Insights
    10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.13.6. SWOT Analysis
    10.7.13.7. Geographic Footprint
    10.7.14. Ipsen Pharma
    10.7.14.1. Company Details
    10.7.14.2. Business Overview
    10.7.14.3. Product Portfolio
    10.7.14.4. Financial Insights
    10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.14.6. SWOT Analysis
    10.7.14.7. Geographic Footprint
    10.7.15. Oramed Pharmaceuticals Inc.
    10.7.15.1. Company Details
    10.7.15.2. Business Overview
    10.7.15.3. Product Portfolio
    10.7.15.4. Financial Insights
    10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.15.6. SWOT Analysis
    10.7.15.7. Geographic Footprint
    10.7.16. Pfizer Inc.
    10.7.16.1. Company Details
    10.7.16.2. Business Overview
    10.7.16.3. Product Portfolio
    10.7.16.4. Financial Insights
    10.7.16.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.16.6. SWOT Analysis
    10.7.16.7. Geographic Footprint
    10.7.17. Sanofi SA
    10.7.17.1. Company Details
    10.7.17.2. Business Overview
    10.7.17.3. Product Portfolio
    10.7.17.4. Financial Insights
    10.7.17.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.17.6. SWOT Analysis
    10.7.17.7. Geographic Footprint
    10.7.18. VeroScience LLC
    10.7.18.1. Company Details
    10.7.18.2. Business Overview
    10.7.18.3. Product Portfolio
    10.7.18.4. Financial Insights
    10.7.18.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.18.6. SWOT Analysis
    10.7.18.7. Geographic Footprint
  - 10.7.19. Other Key Players
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 2. Global Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 3. Global Endocrinology Drugs Market Value (US$ Mn), By Region, 2019-2033
- Table 4. North America Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 5. North America Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 6. North America Endocrinology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 7. The US Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 8. The US Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 9. Canada Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 10. Canada Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 11. Europe Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 12. Europe Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 13. Europe Endocrinology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 14. Germany Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 15. Germany Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 16. The UK Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 17. The UK Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 18. France Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 19. France Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 20. Spain Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 21. Spain Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 22. Italy Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 23. Italy Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 24. Russia Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 25. Russia Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 26. Netherland Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 27. Netherland Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 28. Rest of Europe Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 29. Rest of Europe Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 30. Asia Pacific Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 31. Asia Pacific Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 32. Asia Pacific Endocrinology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 33. China Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 34. China Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 35. India Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 36. India Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 37. Japan Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 38. Japan Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 39. South Korea Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 40. South Korea Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 41. Australia Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 42. Australia Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 43. New Zealand Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 44. New Zealand Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 45. Singapore Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 46. Singapore Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 47. Thailand Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 48. Thailand Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 49. Vietnam Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 50. Vietnam Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 51. Rest of Asia Pacific Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 52. Rest of Asia Pacific Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 53. Latin America Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 54. Latin America Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 55. Latin America Endocrinology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 56. Brazil Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 57. Brazil Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 58. Mexico Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 59. Mexico Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 60. Rest of Latin America Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 61. Rest of Latin America Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 62. Middle East & Africa Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 63. Middle East & Africa Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 64. Middle East & Africa Endocrinology Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 65. South Africa Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 66. South Africa Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 67. Saudi Arabia Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 68. Saudi Arabia Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 69. UAE Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 70. UAE Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 71. Rest of Middle East & Africa Endocrinology Drugs Market Value (US$ Mn), By Therapy Area, 2019-2033
- Table 72. Rest of Middle East & Africa Endocrinology Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
List of Figures
- Figure 1. Global Endocrinology Drugs Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Endocrinology Drugs Market
- Figure 5. Global Endocrinology Drugs Market Analysis, By Therapy Area, 2019, 2023 and 2033
- Figure 6. Global Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
- Figure 7. Global Endocrinology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 8. Global Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 9. Global Endocrinology Drugs Market Analysis, By Region, 2019, 2023 and 2033
- Figure 10. Global Endocrinology Drugs Market Attractiveness Analysis, By Region
- Figure 11. North America Endocrinology Drugs Market Analysis, By Therapy Area, 2019, 2023 and 2033
- Figure 12. North America Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
- Figure 13. North America Endocrinology Drugs Market (US$ Mn), by Diabetes Drugs, 2019-2033
- Figure 14. North America Endocrinology Drugs Market (US$ Mn), by Human Growth Hormone (hGH), 2019-2033
- Figure 15. North America Endocrinology Drugs Market (US$ Mn), by Thyroid Hormone Disorders, 2019-2033
- Figure 16. North America Endocrinology Drugs Market (US$ Mn), by Adrenal Insufficiency, 2019-2033
- Figure 17. North America Endocrinology Drugs Market (US$ Mn), by Other Therapy Areas, 2019-2033
- Figure 18. North America Endocrinology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 19. North America Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 20. North America Endocrinology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 21. North America Endocrinology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 22. North America Endocrinology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 23. North America Endocrinology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 24. North America Endocrinology Drugs Market Attractiveness Analysis, By Country
- Figure 25. Europe Endocrinology Drugs Market Analysis, By Therapy Area, 2019, 2023 and 2033
- Figure 26. Europe Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
- Figure 27. Europe Endocrinology Drugs Market (US$ Mn), by Diabetes Drugs, 2019-2033
- Figure 28. Europe Endocrinology Drugs Market (US$ Mn), by Human Growth Hormone (hGH), 2019-2033
- Figure 29. Europe Endocrinology Drugs Market (US$ Mn), by Thyroid Hormone Disorders, 2019-2033
- Figure 30. Europe Endocrinology Drugs Market (US$ Mn), by Adrenal Insufficiency, 2019-2033
- Figure 31. Europe Endocrinology Drugs Market (US$ Mn), by Other Therapy Areas, 2019-2033
- Figure 32. Europe Endocrinology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 33. Europe Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 34. Europe Endocrinology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 35. Europe Endocrinology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 36. Europe Endocrinology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 37. Europe Endocrinology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 38. Europe Endocrinology Drugs Market Attractiveness Analysis, By Country
- Figure 39. Asia Pacific Endocrinology Drugs Market Analysis, By Therapy Area, 2019, 2023 and 2033
- Figure 40. Asia Pacific Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
- Figure 41. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Diabetes Drugs, 2019-2033
- Figure 42. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Human Growth Hormone (hGH), 2019-2033
- Figure 43. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Thyroid Hormone Disorders, 2019-2033
- Figure 44. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Adrenal Insufficiency, 2019-2033
- Figure 45. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Other Therapy Areas, 2019-2033
- Figure 46. Asia Pacific Endocrinology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 47. Asia Pacific Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 48. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 49. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 50. Asia Pacific Endocrinology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 51. Asia Pacific Endocrinology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 52. Asia Pacific Endocrinology Drugs Market Attractiveness Analysis, By Country
- Figure 53. Latin America Endocrinology Drugs Market Analysis, By Therapy Area, 2019, 2023 and 2033
- Figure 54. Latin America Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
- Figure 55. Latin America Endocrinology Drugs Market (US$ Mn), by Diabetes Drugs, 2019-2033
- Figure 56. Latin America Endocrinology Drugs Market (US$ Mn), by Human Growth Hormone (hGH), 2019-2033
- Figure 57. Latin America Endocrinology Drugs Market (US$ Mn), by Thyroid Hormone Disorders, 2019-2033
- Figure 58. Latin America Endocrinology Drugs Market (US$ Mn), by Adrenal Insufficiency, 2019-2033
- Figure 59. Latin America Endocrinology Drugs Market (US$ Mn), by Other Therapy Areas, 2019-2033
- Figure 60. Latin America Endocrinology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 61. Latin America Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 62. Latin America Endocrinology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 63. Latin America Endocrinology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 64. Latin America Endocrinology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 65. Latin America Endocrinology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 66. Latin America Endocrinology Drugs Market Attractiveness Analysis, By Country
- Figure 67. Middle East & Africa Endocrinology Drugs Market Analysis, By Therapy Area, 2019, 2023 and 2033
- Figure 68. Middle East & Africa Endocrinology Drugs Market Attractiveness Analysis, By Therapy Area
- Figure 69. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Diabetes Drugs, 2019-2033
- Figure 70. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Human Growth Hormone (hGH), 2019-2033
- Figure 71. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Thyroid Hormone Disorders, 2019-2033
- Figure 72. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Adrenal Insufficiency, 2019-2033
- Figure 73. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Other Therapy Areas, 2019-2033
- Figure 74. Middle East & Africa Endocrinology Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 75. Middle East & Africa Endocrinology Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 76. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 77. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 78. Middle East & Africa Endocrinology Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 79. Middle East & Africa Endocrinology Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 80. Middle East & Africa Endocrinology Drugs Market Attractiveness Analysis, By Country
- AbbVie Inc. Company Profile
- AstraZeneca Plc Company Profile
- Novartis AG Company Profile
- Eli Lilly and Company
- Merck KGaA Company Profile
- Novo Nordisk A/S Company Profile
- Sanofi Company Profile
- Takeda Pharmaceutical Company Limited.
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients